BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  Atom Therapeutics and China Medical System Holdings Enter Exclusive Commercialization Agreement for Lingdolinurad (ABP-671) to Treat Chronic Gout and Hyperuricemia

  December 3, 2024

   · 

  4 min read
• Press Releases

  Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial

  December 3, 2024

   · 

  12 min read
• Press Releases

  Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024

  December 3, 2024

   · 

  4 min read
• Press Releases

  COUR Pharmaceuticals Enters Collaboration and Licensing Agreement with Genentech to Develop and Commercialize Tolerogenic Therapy for the Treatment of an Autoimmune Disease

  December 3, 2024

   · 

  2 min read
• Press Releases

  Caris Life Sciences to Showcase Research Highlighting the Clinical Value of Comprehensive Molecular Profiling at the 2024 San Antonio Breast Cancer Symposium

  December 3, 2024

   · 

  9 min read
• Press Releases

  Mirion to Detail Financial Targets and Long-term Strategy at Today’s Investor Day

  December 3, 2024

   · 

  13 min read
• Press Releases

  Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors

  December 3, 2024

   · 

  10 min read
• Press Releases

  Praxis Precision Medicines to Present at Upcoming December Investor Conferences

  December 3, 2024

   · 

  2 min read
• Press Releases

  PolarityBio Announces Interim Enrollment Achieved in SkinTE’s Phase III Pivotal Study

  December 3, 2024

   · 

  1 min read
• Press Releases

  DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia

  December 3, 2024

   · 

  11 min read